Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatment

Published:2015-08 Issue:8 Volume:10 Page:1257-1260
ISSN:1746-0913
Container-title:Future Microbiology
language:en
Short-container-title:Future Microbiology

Author:

Srikrishna Geetha¹²³,Gupta Shashank¹²³,Dooley Kelly E¹²⁴,Bishai William R¹²³

Affiliation:

1. Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Room 108, 1550 Orleans St, Baltimore, MD 21231, USA

2. Division of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, MD, USA

3. Howard Hughes Medical Institute, Chevy Chase, MD, USA

4. Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Publisher

Future Medicine Ltd

Subject

Microbiology (medical),Microbiology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/FMB.15.56

Reference21 articles.

1. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

2. Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism

3. Verapamil, and Its Metabolite Norverapamil, Inhibit Macrophage-induced, Bacterial Efflux Pump-mediated Tolerance to Multiple Anti-tubercular Drugs

4. Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistantMycobacterium tuberculosisthrough Efflux

5. Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical discussion on drug efflux in Mycobacterium tuberculosis;FEMS Microbiology Reviews;2021-10-12

2. The Impact of Hypertension and Use of Calcium Channel Blockers on Tuberculosis Treatment Outcomes;Clinical Infectious Diseases;2020-09-24

3. The impact of hypertension and use of calcium channel blockers on tuberculosis treatment outcomes;2020-09-03

4. Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs;Expert Review of Anti-infective Therapy;2020-05-20

5. Targeting Bedaquiline Mycobacterial Efflux Pump to Potentially Enhance Therapy in Mycobacterium Abscessus;The International Journal of Mycobacteriology;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3